OmpAtb Antigen Tuberculosis Diagnosis Specificity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing tuberculosis, particularly using ESAT-6 and CFP-10 antigens, suffer from cross-reactivity with Mycobacterium kansasii, leading to false negatives and reduced sensitivity, complicating the management of tuberculosis due to the high similarity in genes between M. bovis and M. kansasii.
Innovation Solution
The use of OmpAtb, a bacterial outer membrane protein specific to M. tuberculosis and M. bovis, as an antigen in diagnostic assays to detect cell-mediated immune responses or antibodies, potentially combined with other antigens like PPD, ESAT-6, or CFP-10, to enhance specificity and sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If ESAT-6 and CFP-10 antigens are used for tuberculosis diagnosis, then specificity is improved, but cross-reactivity with Mycobacterium kansasii occurs leading to false results
Solution Approach 1:
The patent segments the diagnostic approach by using multiple distinct antigens (ESAT-6, CFP-10, and OmpA) instead of relying on a single antigen. This segmentation allows the diagnostic system to differentiate between true MTC infections and false positives from M. kansasii, as different antigens elicit different immune response patterns in different mycobacterial infections.
Solution Approach 2:
The patent employs a composite antigen approach by combining multiple mycobacterial antigens (ESAT-6, CFP-10, and OmpA) into a multi-antigen diagnostic system. This composite strategy leverages the unique immunogenic properties of each antigen to achieve both high specificity for MTC and high sensitivity for detecting tuberculosis, while the pattern recognition algorithm processes the combined immune responses to distinguish true positives from false positives.
2Measurement precision
If different antigens are used to detect tuberculosis, then sensitivity appears lower than tuberculin, but specificity is improved
Solution Approach 1:
The patent merges multiple antigen-specific immune responses into a comprehensive diagnostic evaluation. By simultaneously measuring immune responses to ESAT-6, CFP-10, and OmpA, and integrating these measurements through pattern recognition, the system achieves both high specificity and high sensitivity, overcoming the limitation of using individual antigens alone.
Solution Approach 2:
The patent changes the diagnostic parameters by moving from single-antigen detection to multi-antigen pattern recognition. The system evaluates multiple immune response parameters simultaneously (responses to different antigens) and uses algorithmic processing to interpret the pattern, thereby transforming the diagnostic capability to achieve both high specificity and sensitivity.
3Device complexity
If M. kansasii is not included in MTC but has highly identical genes to M. bovis, then classification is simplified, but test interpretation becomes complicated due to false positives
Solution Approach 1:
The patent implements feedback through pattern recognition algorithms that analyze the pattern of immune responses across multiple antigens. The system provides feedback by comparing the observed response pattern against expected patterns for different mycobacterial infections, enabling automated differentiation between MTC infections and M. kansasii infections, thereby simplifying test interpretation despite genetic similarities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
OmpAtb demonstrates high specificity for M. bovis and M. tuberculosis, providing accurate diagnoses in cases where ESAT-6 or CFP-10 tests yield false negatives, and can be used to design assays with increased sensitivity when combined with other antigens, improving the reliability of tuberculosis diagnosis.
Implementation Method 1
detecting the presence of cell-mediated immune-response resulting from the incubation or detecting antibodies to mycobacterial antigens
Implementation Method 2
analysed for the presence of a cell-mediated immune response to mycobacterial antigens or of mycobacterial antibodies
Data Source
AI summary
A method for the diagnosis of a tuberculosis infection caused by Mycobacteria belonging to the Mycobacteria tuberculosis complex group (MTC) in an animal including a human being, which comprises in vitro-detection of cell-mediated immune response to OmpAtb and/or antibodies against OmpAtb in a sample taken from that animal.